Anthelmintics and preparations thereof
Anthelmintic medicaments and preparations for retail sale
HSN 3004 90 21 (Anthelmintics and preparations thereof) is subject to drug import licensing and registration under the Drugs and Cosmetics Act, 1940, administered by the Central Drugs Standard Control Organisation (CDSCO). The Directorate General of Foreign Trade (DGFT) classifies this tariff line as subject to policy conditions, including a prohibition on the import of oxytocin under DGFT Notification 09/2015-2020 dated 23-05-2022.
- Registration certificate from CDSCO
- Import licence for drugs from CDSCO
- Batch release certificate from manufacturer
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Ensure the anthelmintic product holds a valid CDSCO registration certificate and import licence for drugs before filing the bill of entry. Upload the registration certificate (document code 101dc1) and the import licence for drugs (document code 9111dc) in e-Sanchit; customs out-of-charge will not be granted without these documents.Drugs and Cosmetics Act, 1940 · document codes 101dc1 and 9111dc · CDSCO import licensing regime
- 2Upload the Certificate of Analysis — Drug (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc) in e-Sanchit at the bill of entry stage. The proper officer must verify all five mandatory documents are present before granting out-of-charge on PGA-facilitated bills.CDSCO mandatory document set · document codes 0010dc, 0030dc, 0110dc
- 3Confirm the consignment does not contain oxytocin, the import of which is prohibited under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022. Import of oxytocin reference standards is the sole permitted exception, and only subject to a test licence issued by DGCI/CDSCO for test and analysis purposes exclusively.S.O. 2357(E) · DGFT Notification 09/2015-2020 dated 23-05-2022
The most common error on this tariff line is failing to distinguish between the oxytocin general-import prohibition and the narrow research-use carve-out: a test licence issued by DGCI/CDSCO authorises oxytocin reference standards solely for test and analysis, and any consignment presented as a therapeutic or prophylactic preparation containing oxytocin is liable to outright confiscation with no rectification window. Separately, anthelmintic importers sometimes upload only the registration certificate and omit the batch release certificate (0030dc) or the label (0110dc), which triggers hold pending re-upload and accrues demurrage.